[1] Schmidley JW. Free radicals in central nervous systemischemia[J]. Stroke, 1990, 21(7): 1086-1090. [2] Lee JM, Grabb MC, Zipfel GJ, et al. Brain tissue responses to ischemia[J]. J ClinInvest, 2000, 106(6): 723-731. [3] Watanabe T, Tahara M, Todo S. The novel antioxidant edarav one: from bench to bedside[J]. Cardiovascular Therapeutic, 2008, 26(2): 101-104. [4] Long a EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy inrats[J]. Stroke, 1989, 20(1): 84-91. [5] 陈维洲. 脑缺血和脑血流实验法[M] // 徐叔云, 卞如濂, 陈修, 主编. 药理实验方法学. 3 版. 北京:人民卫生出版社, 2002: 1066-1067. [6] Katayama Y, Igarashi H. Advance s in the diagnosis and treatment of cerebra ischemia during the acute phase[J]. Rinsho Shinkeigaku, 2003, 43(11): 887-890. [7] Higashi Y. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidativ e stress [J]. Expert Opin Pharma cother, 2009, 10(2): 323-331. [8] Xiao B, Bi FF, Hu YQ, et al. Edarav one neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats[J]. Neurotox Res, 2007, 12(3): 155-162. [9] SudaS, Igarashi H, Arai Y, et al. Effect of edarav one, a free radical scavenger, on ischemic cerebral edema assessed by mag ne tic resonance imaging[J]. Neurol Med Chir, 2007, 47(5): 197-201. [10] 李榕, 罗春霞, 迟路湘. 重组人生长激素对局灶性脑缺血大鼠神经功能恢复的影响[J]. 中国临床药理学与治疗学, 2007, 12(11): 1288-1291. [11] Tu XK, Yang WZ, Shi SS, et al. 5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix me tallopro teinase 9 [J]. Neurol Res, 2009, 31(8): 848-852. |